Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
about
Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseasesMitochondria as a therapeutic target in heart failureEffect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarctionMitochondria in heart failureHeart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathyCancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory SupportImprovement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril.Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.ATP synthase subunit alpha and LV mass in ischaemic human hearts.Energy metabolism in heart failure.Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression.From mitochondria to disease: role of the renin-angiotensin system.Mitochondria and heart failure: new insights into an energetic problem.Metabolic remodelling of the failing heart: beneficial or detrimental?Mechanotransduction and Metabolism in Cardiomyocyte Microdomains.Impact of dietary fatty acids on cardiac arrhythmogenesis.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Cardiac transcriptional response to acute and chronic angiotensin II treatments.Metabolic remodelling in hypertrophied and failing myocardium: a review.Bioenergetic remodeling of heart during treatment of spontaneously hypertensive rats with enalapril.Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats.Mechanistic Role of Thioredoxin 2 in Heart Failure.Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat.
P2860
Q26866951-3D8A1F84-54C3-454B-BCA7-EF19D9C7325EQ27005632-587EBBBF-1EA1-4018-B83B-2332C205E68FQ28362704-B1EE484C-16DC-4212-9042-574EBB72DD48Q28385915-3A2FFF04-ABBC-4A66-8C5A-60A9A3E0C16CQ28544978-1C6E2857-436B-4734-B2E4-1B7123950BFCQ30426853-91747D95-505B-46AE-9135-0BC80F3CDC19Q33677357-71EBCC71-A5EF-47A6-A2EC-C7126DCF1F3EQ35028690-CBE29D00-CAD8-49DE-9775-DB5A1D90B77FQ35214168-0008C6B9-79A1-4BBF-BA0E-AAE2467ACB70Q35531382-255C9E5E-1642-4AE3-B253-8632FB3016D2Q35602060-9723FDB8-74FF-4019-BF01-A5FD077CEFF4Q36216855-AC1B97D0-739E-488D-A91D-F66358F74CE7Q36912517-F35D20AF-04D8-488E-A4A3-62F05D4738A2Q36929305-C958E993-2E7D-4272-90BF-28E3DA4CBA5EQ37206330-20E6019A-F0D8-4AC1-8D0A-46793F5BCFBEQ37293624-889655DD-CB28-4A72-97EF-BB4AB65AC6FDQ37511851-C6C3CB2E-FFDC-409B-A364-8B880E5D0C3DQ37609739-06E0A448-2896-40EC-A469-0F70219689CDQ38454084-808A5295-EC0C-436E-A1FF-05F11E7365ECQ38521958-13501FFE-6DB0-4C08-A828-6A9C94D3E20BQ39395331-08D8149B-D30C-4F12-B212-AADC7AF33B4DQ44068468-6557CAE6-6529-416E-9FFF-EDB19CB56DE7Q44546130-44BEAF4F-8BDB-4C4A-B274-4567F9DD0BDEQ44569117-554D310E-46F5-4DB9-B0C3-805DDE036228Q44925672-E3D9DBB5-C5E7-4D89-BC5C-3F0CD644E393Q44963448-54C8CFA2-23F6-4D76-8789-8CA95B3D472CQ46359834-1962F518-E99B-48E2-8AF4-F8E76A0C6962Q46844264-2972A3B4-033A-46A3-84A4-A3F1DEEA0D91
P2860
Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Effects of long-term therapy w ...... llowing myocardial infarction.
@en
Effects of long-term therapy w ...... llowing myocardial infarction.
@nl
type
label
Effects of long-term therapy w ...... llowing myocardial infarction.
@en
Effects of long-term therapy w ...... llowing myocardial infarction.
@nl
prefLabel
Effects of long-term therapy w ...... llowing myocardial infarction.
@en
Effects of long-term therapy w ...... llowing myocardial infarction.
@nl
P2093
P1476
Effects of long-term therapy w ...... llowing myocardial infarction.
@en
P2093
P304
P356
10.1016/S0022-2828(95)91551-6
P577
1995-10-01T00:00:00Z